The ClearCell™ System and CTChip®
For the label-free isolation, enumeration and retrieval of viable Circulating Tumour Cells (CTCs) from blood.
The next generation non-invasive 'liquid biopsy' for cancer. 
 |
All-in-one Research Use solution for cell isolation, enumeration, staining & retrieval |
|
Intact viable CTCs |
|
Label-free |
|
Small blood volume required |
|
Real-time imaging |
 
|
Circulating tumour cells or CTCs represent an important key in cancer detection and treatment. They are associated with metastasis, and studies show that the isolation of these rare cells has important prognostic and therapeutic implications. As such, enumerating CTCs in blood is crucial in helping clinicians make timely decisions and for patients to receive potentially personalised life-saving treatments.
Clearbridge BioMedics presents the ClearCell™ System, which comprises the CTChip® and ClearCell™ Unit. It is one of the world's first systems capable of effectively detecting and isolating intact, viable CTCs from small quantities of whole, unprocessed blood. CTCs isolated on the CTChips® can then be stained directly for identification, or retrieved for further molecular analysis.
With its patent pending microfluidic based design, the CTChip® can potentially be the next generation of non-invasive 'liquid biopsy' for cancer treatment and management.
Please contact us for more information.
|
